Literature DB >> 30499000

Serum Extracellular Vesicles Retard H9C2 Cell Senescence by Suppressing miR-34a Expression.

Yang Liu1, Zhuyuan Liu2, Yuan Xie1, Cuimei Zhao1, Jiahong Xu3.   

Abstract

Extracellular vesicles (EVs) are small-sized membrane-surrounded structures released from cells into the blood, which play important roles in regulating various biological processes. However, the role of EVs in Doxorubicin (DOX)-induced cardiomyocytes senescence remains elusive. In this study, we found that human serum EVs inhibited DOX-induced senescence in H9C2 cells, which was abolished by miR-34a mimic. Our study also proved that miR-34a mediated DOX-induced H9C2 cell senescence by targeting phosphatase 1 nuclear targeting subunit (PNUTS). In addition to the downregulation of miR-34a, EVs could upregulate the expression of PNUTS. Moreover, the inhibitory effect of serum EVs on DOX-induced H9C2 cell senescence was also impeded by PNUTS siRNA. In conclusion, our study suggests that serum EVs retard H9C2 cell senescence through the miR-34a/PNUTS pathway, providing a potential therapy for cardiac aging.

Entities:  

Keywords:  Cell senescence; Phosphatase 1 nuclear targeting subunit; Serum extracellular vesicles; miR-34a

Mesh:

Substances:

Year:  2018        PMID: 30499000     DOI: 10.1007/s12265-018-9847-4

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  35 in total

1.  Keep PNUTS in your heart.

Authors:  Francesco S Loffredo; James R Pancoast; Richard T Lee
Journal:  Circ Res       Date:  2013-07-05       Impact factor: 17.367

2.  MicroRNA-34a: a new piece in the cardiac aging puzzle.

Authors:  Ying Ann Chiao
Journal:  Circ Cardiovasc Genet       Date:  2013-08

3.  Serum extracellular vesicles promote proliferation of H9C2 cardiomyocytes by increasing miR-17-3p.

Authors:  Zhuyuan Liu; Zhongrong Zhang; Jianhua Yao; Yuan Xie; Qiying Dai; Yuhui Zhang; Lei Zhou
Journal:  Biochem Biophys Res Commun       Date:  2018-04-01       Impact factor: 3.575

4.  Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model.

Authors:  H Pêche; K Renaudin; G Beriou; E Merieau; S Amigorena; M C Cuturi
Journal:  Am J Transplant       Date:  2006-07       Impact factor: 8.086

5.  miR-21 suppression prevents cardiac alterations induced by d-galactose and doxorubicin.

Authors:  Yihua Bei; Xiaoting Wu; Dragos Cretoiu; Jing Shi; Qiulian Zhou; Shenghui Lin; Hui Wang; Yan Cheng; Haifeng Zhang; Junjie Xiao; Xinli Li
Journal:  J Mol Cell Cardiol       Date:  2018-01-09       Impact factor: 5.000

Review 6.  Stem Cell-Derived Exosomes, Autophagy, Extracellular Matrix Turnover, and miRNAs in Cardiac Regeneration during Stem Cell Therapy.

Authors:  Priyanka Prathipati; Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

Review 7.  Stem cells and exosomes in cardiac repair.

Authors:  Dinender K Singla
Journal:  Curr Opin Pharmacol       Date:  2016-02-03       Impact factor: 5.547

8.  The complete exosome workflow solution: from isolation to characterization of RNA cargo.

Authors:  Jeoffrey Schageman; Emily Zeringer; Mu Li; Tim Barta; Kristi Lea; Jian Gu; Susan Magdaleno; Robert Setterquist; Alexander V Vlassov
Journal:  Biomed Res Int       Date:  2013-09-25       Impact factor: 3.411

9.  Cardiac endothelial cell-derived exosomes induce specific regulatory B cells.

Authors:  Jiangping Song; Xiao Chen; Mangyuan Wang; Yong Xing; Zhe Zheng; Shengshou Hu
Journal:  Sci Rep       Date:  2014-12-23       Impact factor: 4.379

10.  Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair.

Authors:  Zhiwei Zhang; Junjie Yang; Weiya Yan; Yangxin Li; Zhenya Shen; Takayuki Asahara
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

View more
  8 in total

1.  Exosomes in Cardiovascular Diseases and Treatment: Experimental and Clinical Aspects.

Authors:  Jing Wang; Chenglin Zhao; Junjie Xiao
Journal:  J Cardiovasc Transl Res       Date:  2019-01-07       Impact factor: 4.132

2.  MicroRNA-221 promotes proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs) by targeting tissue inhibitor of metalloproteinases-3 (TIMP3).

Authors:  Yan Yan; Ying Xu; Gehui Ni; Siqi Wang; Xinli Li; Juan Gao; Haifeng Zhang
Journal:  Cardiovasc Diagn Ther       Date:  2020-08

Review 3.  Emerging Role of Non-Coding RNAs in Senescence.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Aria Baniahmad; Wojciech Branicki; Mohammad Taheri; Ahmad Eghbali
Journal:  Front Cell Dev Biol       Date:  2022-07-05

Review 4.  Gene therapy for cardiovascular diseases in China: basic research.

Authors:  Jiali Deng; Mengying Guo; Guoping Li; Junjie Xiao
Journal:  Gene Ther       Date:  2020-04-27       Impact factor: 5.250

Review 5.  Extracellular vesicles as mediators and markers of acute organ injury: current concepts.

Authors:  Birte Weber; Niklas Franz; Ingo Marzi; Dirk Henrich; Liudmila Leppik
Journal:  Eur J Trauma Emerg Surg       Date:  2021-02-03       Impact factor: 3.693

Review 6.  Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity.

Authors:  Guoxia Zhang; Xinyu Yang; Xin Su; Na An; Fan Yang; Xinye Li; Yuchen Jiang; Yanwei Xing
Journal:  Oxid Med Cell Longev       Date:  2022-09-12       Impact factor: 7.310

Review 7.  Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments.

Authors:  Wanli Sun; Juping Xu; Li Wang; Yuchen Jiang; Jingrun Cui; Xin Su; Fan Yang; Li Tian; Zeyu Si; Yanwei Xing
Journal:  Front Cardiovasc Med       Date:  2022-08-23

Review 8.  Roles of extracellular vesicles in the aging microenvironment and age-related diseases.

Authors:  Yujia Yin; Huihui Chen; Yizhi Wang; Ludi Zhang; Xipeng Wang
Journal:  J Extracell Vesicles       Date:  2021-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.